scispace - formally typeset
Open AccessJournal ArticleDOI

The role of antipsychotics against COVID-19: A topic for debate.

M Canal-Rivero, +5 more
- 08 Jul 2021 - 
- Vol. 235, pp 5-6
Reads0
Chats0
About: 
This article is published in Schizophrenia Research.The article was published on 2021-07-08 and is currently open access. It has received 2 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study

Manuel Canal-Rivero, +8 more
- 01 Jan 2023 - 
TL;DR: In this article , the authors explore the prevalence and temporal pattern of COVID-19 in comprehensive network of long-term mental health facilities in Spain and estimate the effect of having a severe mental health diagnosis on prevalence and COVID19 outcomes.
Journal ArticleDOI

Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses

Hiram Tendilla-Beltrán, +4 more
- 01 Apr 2023 - 
References
More filters
Journal ArticleDOI

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Kenneth I. Zheng, +10 more
- 01 Jul 2020 - 
TL;DR: The data demonstrate that the risk of obesity to COVID-19 severity is greater in those with, than those without MAFLD, and the presence of obesity inMAFLD patients was associated with a ~ 6-fold increased risk of severe COVID -19 illness.
Journal ArticleDOI

Psychiatry in the aftermath of COVID-19.

Eduard Vieta, +2 more
- 01 Apr 2020 - 
TL;DR: The aftermath of COVID-19 will shine a light on certain aspects of psychiatry as a medical specialty, the psychological aspects of medical practice, liaison and consultative psychiatry, home hospitalization, and virtual or telemedicine outpatient care.
Journal ArticleDOI

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study

María José Morlán-Coarasa, +8 more
- 12 Sep 2016 - 
TL;DR: The results support the importance of assessing the potential development of NAFLD in schizophrenia spectrum patients receiving antipsychotic medication as well as the link between cardiometabolic risk, non-alcoholic fatty liver disease (NAFLD), and antipsychotics.
Journal ArticleDOI

Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population.

M Canal-Rivero, +5 more
- 19 Feb 2021 - 
Journal ArticleDOI

Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.

Beatriz Oda Plasencia-García, +5 more
- 07 Jan 2021 - 
TL;DR: A systematic review of drug-drug interactions between antipsychotics and COVID-19 treatment was conducted in this article, where the authors made a recommendation agreed by consensus that clinicians should be aware of the likely risk of drugdrug interaction with COVID19 medication and may benefit from taking into account present recommendations of use to preserve patient safety.